| Literature DB >> 26333354 |
Luciane Kanashiro-Galo1, Carla Pagliari2, Tania Cristina Barboza3, Arival Cardoso de Brito4, Marilia Brasil Xavier5, Clivia Maria Moraes de Oliveira4, Deborah Aben Athar Unger4, Mirian Nacagami Sotto1, Juarez Antonio Simões Quaresma5, Maria Irma Seixas Duarte1.
Abstract
Jorge Lobo's disease (JLD) is a chronic granulomatous mycosis described in various Latin American countries. The main objective of the present study was to investigate the possible role of Th17 and Foxp3+ Treg cells in the pathogenesis of Jorge Lobo's disease. Human skin biopsies were submitted to an immunohistochemistry protocol to detect Foxp3, interleukin (IL)-1beta, CD25, IL-6, IL-17, and IL-23. The epidermis presented acanthosis, hyperkeratosis, and frequent presence of fungi. The dermis presented inflammatory infiltrate comprising macrophages, lymphocytes, epithelioid and multinucleated cells, and an intense number of fungi. Foxp3+ Treg cells and IL-17+ cells were visualized in lymphocytes in the inflammatory infiltrate. IL-1, IL-2R (CD25), IL-6, and IL-23 were visualized in the dermis, intermingled with fungal cells, permeating or participating of the granuloma. Following IL-17, the most prominent cytokine was IL-6. IL-23 and cells expressing CD25 were present in fewer number. The comparative analysis between IL-17 and Foxp3 demonstrated a statistically significant increased number of IL-17+ cells. Th17 cells play a role in the immune response of JLD. IL-1beta and IL-6 added to the previously described increased number of TGF-beta would stimulate such pattern of response. Th17 cells could be present as an effort to modulate the local immune response; however, high levels of a Th17 profile could overcome the role of Treg cells. The unbalance between Treg/Th17 cells seems to corroborate with the less effective immune response against the fungus.Entities:
Keywords: Jorge Lobo's Disease; Th17 cells; immune response; regulatory T cells
Mesh:
Substances:
Year: 2015 PMID: 26333354 DOI: 10.1093/mmy/myv069
Source DB: PubMed Journal: Med Mycol ISSN: 1369-3786 Impact factor: 4.076